AB-CHMINACA
Summary
A synthetic cannabinoid related to AB-FUBINACA which has had some mild popularity. There have been reports of death in overdose, similar to AB-FUBINACA and it has a low threshold dose. Exercise caution.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 50-100ug | 100-250ug | 250-400ug | 400ug+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Peak |
|---|---|---|
| Oral | 20-80 min | 5-12 hrs |
Tolerance
Build-up
develops over weeks of regular use via CB1 receptor downregulation
Reset
2–4 weeks for most users; heavy users may need longer
Tolerance Decay
Full tolerance
3d
Half tolerance
21d
Baseline
~28d
Effects
Positive
- Stimulation
- Mental/physical stimulation
Negative
- Increased heart rate
- Insomnia
- Pupil dilation
- Nausea
- Vasoconstriction
- Restlessness
- Sedation
- Decreased appetite
Positive
- Euphoria
- Cognitive euphoria
- Wakefulness
- Empathy
- Analysis enhancement
Negative
- Anxiety
- Confusion
- Compulsive redosing
- Time distortion
- Talkativeness
Positive
- Color enhancement
- Increased music appreciation
- Brightened colour
- Tactile enhancement
Negative
- Light sensitivity
- Appetite suppression
- Disinhibition
- Dehydration
- Dulled perception
- Drifting
Combinations
AB-CHMINACA's nerd page
Pharmacology, chemical data, effect profiles, and more
→